Summary:
Acquired an additional 297 BTC, bringing total holdings to 1,570 BTC with a yield of 58.4%
Launching a new $50 million ATM offering, increasing total potential to $100 million
BTC Yield for October 1 to November 22, 2024, recorded at 37.1%
BTC Yield from July 1 to November 22, 2024, reached 58.4%
Semler Scientific adopts Bitcoin as a primary treasury asset
Semler Scientific's Bitcoin and ATM Activity Update
- Acquired an additional 297 BTC; total holdings now at 1,570 BTC with a yield of 58.4%!
- Launching a new $50 million ATM offering, raising total potential to $100 million!
Semler Scientific, Inc. (Nasdaq: SMLR), known for its innovative technology products in healthcare, has announced significant updates regarding its bitcoin (BTC) activity and capital markets strategy.
BTC Update
Between November 18-22, 2024, Semler Scientific purchased 297 bitcoins for $29.1 million at an average price of $97,995 per bitcoin. As of November 22, 2024, the company holds 1,570 bitcoins, acquired for a total of $117.8 million at an average price of $75,039 each.
ATM Offering Update
As part of its ongoing strategy, Semler Scientific has filed a prospectus supplement to its existing ATM offering with Cantor Fitzgerald, aiming to raise an additional $50 million. This increases the total ATM offering to $100 million. To date, approximately $50 million has been raised through this initiative.
BTC Yield as a Key Performance Indicator (KPI)
From October 1 to November 22, 2024, Semler's BTC Yield was 37.1%, while from July 1 to November 22, 2024, it reached 58.4%.
Eric Semler, chairman of Semler Scientific, expressed excitement over the strong BTC yield and the company's progress in accumulating bitcoin, which he believes benefits stakeholders.
Understanding BTC Yield
BTC Yield represents the percentage change in the ratio of Semler Scientific's bitcoin holdings to its Assumed Diluted Shares Outstanding, aiding in assessing the effectiveness of its bitcoin acquisition strategy.
The company emphasizes that BTC Yield should not be mistaken for traditional yield measures and does not reflect the historical or future returns for stockholders.
Important Note: This press release does not constitute an offer to sell or buy securities of Semler Scientific.
About Semler Scientific, Inc.
Semler Scientific is a leader in developing healthcare technology products. Its flagship product, QuantaFloÂŽ, is a rapid test for assessing cardiovascular risk. The company has also adopted Bitcoin as a primary treasury asset, enhancing its financial strategy.
Comments